CAS RN: 517870-15-4
METHYL 5-(4-BROMOPHENYL)ISOXAZOLE-3-CARBOXYLATE
Product Availability
Choose a grade to view its available package options.
4 package records4 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250901 |
100g |
In stock |
Shanghai | Inquiry |
| Batchno.20250630 |
1g |
In stock |
Shanghai, Shenzhen, Chengdu | Inquiry |
| Batchno.20250603 |
25g |
In stock |
Shanghai | Inquiry |
| Batchno.20260117 |
5g |
In stock |
Shanghai | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 1g, 5g, 25g, 10g
- Available purity: >97%
- Inventory rows with stock: 3
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 517870-15-4
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 1g |
>97% |
5
In Stock
|
Shenzhen |
Inquiry |
| 5g |
>97% |
5
In Stock
|
Shanghai |
Inquiry |
| 25g |
>97% |
5
In Stock
|
Hong Kong |
Inquiry |
| 10g |
>97% |
0
Out of Stock
|
Shanghai |
Inquiry |
517870-15-4 / methyl 5-(4-bromophenyl)-1,2-oxazole-3-carboxylate
Standard CAS: 517870-15-4
Multi CAS: No
Basic Information
CAS
517870-15-4
Multi CAS
No
Molecular Formula
BC11H8O3Rn
Molecular Weight
282.090000
Exact Mass
280.968760
InChI
InChI=1S/C11H8BrNO3/c1-15-11(14)9-6-10(16-13-9)7-2-4-8(12)5-3-7/h2-6H,1H3
InChIKey
QDMKBPFKVHCOEZ-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
16
Aromatic heavy atom count
11
Fraction Csp3
0.09
Rotatable bonds
2
H-bond acceptors
4
Molar refractivity
60.98
TPSA
52.33
LogP / Solubility
WLOGP
2.89
MLOGP
2.55
XLogP3
2.9
Consensus LogP
2.78
Log S (ESOL)
-3.79
Class (ESOL)
Poorly soluble
Log S (Ali)
-3.96
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-4.13
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.39
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
Yes
Synthetic Accessibility
1.5